{"id":82513,"date":"2026-05-06T15:37:37","date_gmt":"2026-05-06T10:07:37","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=82513"},"modified":"2026-05-06T15:37:39","modified_gmt":"2026-05-06T10:07:39","slug":"paushak-q4-results-fy26-pat-rs-13-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/paushak-q4-results-fy26-pat-rs-13-crore\/","title":{"rendered":"Paushak Q4 Results FY26: PAT Rs 13 Crore on Phosgene Specialty Chemicals for Pharma and Agro"},"content":{"rendered":"<div class=\"meta-block\">\u00a0<\/div>\n<p>Paushak Q4 results FY26 reported net profit of Rs 12.51 crore for the quarter ended March 31, 2026. Paushak Q4 results reflect the company&#8217;s niche position as one of India&#8217;s few manufacturers of phosgene-based specialty chemicals, serving the pharmaceutical and agrochemical sectors with intermediates and fine chemicals that require specialised handling and manufacturing expertise.<\/p>\n<p>Paushak Q4 results are reported as part of the Alembic Group, which provides strategic oversight and synergies in the hazardous specialty chemicals manufacturing space. The Paushak Q4 results business model is characterised by high barriers to entry from regulatory approvals for phosgene manufacturing, specialised plant and safety infrastructure, and long-standing relationships with domestic and international pharmaceutical and agrochemical companies.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Get Free Stock Recommendations on Univest<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/paushak-q4-results-fy26-pat-rs-13-crore\/#Paushak_Q4_FY26_Results_at_a_Glance\" title=\"Paushak Q4 FY26 Results at a Glance\">Paushak Q4 FY26 Results at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/paushak-q4-results-fy26-pat-rs-13-crore\/#Key_Highlights_from_Paushak_Q4_results\" title=\"Key Highlights from Paushak Q4 results\">Key Highlights from Paushak Q4 results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/paushak-q4-results-fy26-pat-rs-13-crore\/#Phosgene_Chemistry_Barrier_Creates_Durable_Moat_in_Paushak_Q4_Results\" title=\"Phosgene Chemistry Barrier Creates Durable Moat in Paushak Q4 Results\">Phosgene Chemistry Barrier Creates Durable Moat in Paushak Q4 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/paushak-q4-results-fy26-pat-rs-13-crore\/#Pharma_and_Agro_Demand_Provides_Stable_Base_for_Paushak_Q4_Results\" title=\"Pharma and Agro Demand Provides Stable Base for Paushak Q4 Results\">Pharma and Agro Demand Provides Stable Base for Paushak Q4 Results<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/paushak-q4-results-fy26-pat-rs-13-crore\/#What_Drove_Paushak_Q4_FY26_Performance\" title=\"What Drove Paushak Q4 FY26 Performance\">What Drove Paushak Q4 FY26 Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/paushak-q4-results-fy26-pat-rs-13-crore\/#Outlook_for_FY27\" title=\"Outlook for FY27\">Outlook for FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/paushak-q4-results-fy26-pat-rs-13-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/paushak-q4-results-fy26-pat-rs-13-crore\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/paushak-q4-results-fy26-pat-rs-13-crore\/#What_was_the_Paushak_Q4_results_FY26_net_profit\" title=\"What was the Paushak Q4 results FY26 net profit?\">What was the Paushak Q4 results FY26 net profit?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/paushak-q4-results-fy26-pat-rs-13-crore\/#What_does_Paushak_make_and_why_does_it_matter_for_Q4_results\" title=\"What does Paushak make and why does it matter for Q4 results?\">What does Paushak make and why does it matter for Q4 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/paushak-q4-results-fy26-pat-rs-13-crore\/#What_is_the_Alembic_Group_connection_in_Paushak_Q4_results\" title=\"What is the Alembic Group connection in Paushak Q4 results?\">What is the Alembic Group connection in Paushak Q4 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/paushak-q4-results-fy26-pat-rs-13-crore\/#What_is_the_outlook_after_Paushak_Q4_results_FY26\" title=\"What is the outlook after Paushak Q4 results FY26?\">What is the outlook after Paushak Q4 results FY26?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/paushak-q4-results-fy26-pat-rs-13-crore\/#Recent_Article\" title=\"Recent Article\">Recent Article<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Paushak_Q4_FY26_Results_at_a_Glance\"><\/span><strong>Paushak Q4 FY26 Results at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q4 FY26<\/th>\n<th>Change \/ Context<\/th>\n<\/tr>\n<tr>\n<td>Q4 PAT<\/td>\n<td>Rs 12.51 crore<\/td>\n<td>Specialty phosgene chemicals<\/td>\n<\/tr>\n<tr>\n<td>Group<\/td>\n<td>Alembic Group company<\/td>\n<td>Strategic support and synergies<\/td>\n<\/tr>\n<tr>\n<td>Core Chemistry<\/td>\n<td>Phosgene-based specialty<\/td>\n<td>High barrier to entry<\/td>\n<\/tr>\n<tr>\n<td>End Markets<\/td>\n<td>Pharma and agrochemical<\/td>\n<td>Stable demand base<\/td>\n<\/tr>\n<tr>\n<td>Manufacturing<\/td>\n<td>Hazardous chemical facility<\/td>\n<td>Regulatory and safety moat<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Track live Paushak financials, analyst ratings and peer comparisons on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Highlights_from_Paushak_Q4_results\"><\/span><strong>Key Highlights from Paushak Q4 results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Phosgene_Chemistry_Barrier_Creates_Durable_Moat_in_Paushak_Q4_Results\"><\/span><strong>Phosgene Chemistry Barrier Creates Durable Moat in Paushak Q4 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Paushak Q4 results benefit from phosgene chemistry manufacturing which requires specialised regulatory approvals, safety infrastructure investment, and trained manpower that create significant barriers to new competition. The Paushak Q4 results moat is reinforced by customer stickiness, as pharmaceutical and agrochemical companies qualifying Paushak as a supplier through rigorous regulatory audits are unlikely to switch sources without significant validation cost. This makes Paushak Q4 results revenue highly predictable and recurring.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Pharma_and_Agro_Demand_Provides_Stable_Base_for_Paushak_Q4_Results\"><\/span><strong>Pharma and Agro Demand Provides Stable Base for Paushak Q4 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Paushak Q4 results revenue is driven by domestic and export demand for phosgene-based intermediates from pharmaceutical API manufacturers and agrochemical companies. The Paushak Q4 results customer base includes established Indian and multinational pharma companies that use phosgene chemistry intermediates in regulated drug manufacturing. Agrochemical demand is also a steady source of Paushak Q4 results revenue.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Drove_Paushak_Q4_FY26_Performance\"><\/span><strong>What Drove Paushak Q4 FY26 Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Paushak Q4 results performance was driven by steady pharma API and agrochemical intermediate demand, high barriers to entry maintaining pricing power, and Alembic Group synergies providing shared infrastructure. The Paushak Q4 results unique phosgene chemistry position in a supply-constrained specialty chemicals niche allows consistent profitability despite being a small-scale company.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Outlook_for_FY27\"><\/span><strong>Outlook for FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Following Paushak Q4 results, FY27 outlook is stable with continued pharma and agro customer demand, potential capacity expansion to serve growing export opportunities, and Alembic Group strategic support. Paushak Q4 results position the company as a quality small-cap specialty chemicals compounder. Analyst targets for Paushak post Q4 results range Rs 12,000 to Rs 16,000.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Paushak Q4 results FY26 confirm PAT of Rs 12.51 crore on steady phosgene specialty chemicals demand. The regulatory moat, Alembic Group backing, and pharma-agro end market stability make Paushak Q4 results a consistent quality specialty chemicals performer. Track live data on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Univest iOS App<\/strong><\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Univest Android App<\/strong><\/a> for live Paushak Q4 results tracking and expert research.<\/p>\n<p><em>Disclaimer: This article is for informational purposes only and does not constitute investment advice. Consult a SEBI-registered financial advisor before making investment decisions.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_Paushak_Q4_results_FY26_net_profit\"><\/span><strong>What was the Paushak Q4 results FY26 net profit?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Paushak Q4 results FY26 reported PAT of Rs 12.51 crore from phosgene-based specialty chemicals manufacturing for pharmaceutical and agrochemical industry customers, supported by the Alembic Group.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Paushak_make_and_why_does_it_matter_for_Q4_results\"><\/span><strong>What does Paushak make and why does it matter for Q4 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Paushak Q4 results are driven by phosgene-based specialty chemicals used as intermediates in pharmaceutical API manufacturing and agrochemical synthesis. Phosgene chemistry creates high entry barriers from regulatory and safety requirements.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Alembic_Group_connection_in_Paushak_Q4_results\"><\/span><strong>What is the Alembic Group connection in Paushak Q4 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Paushak Q4 results benefit from Alembic Group membership, which provides strategic oversight, shared infrastructure, and synergies with Alembic Pharmaceuticals for specialty chemical procurement and R&amp;D support.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_outlook_after_Paushak_Q4_results_FY26\"><\/span><strong>What is the outlook after Paushak Q4 results FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Following Paushak Q4 results, FY27 outlook is stable with pharma and agro demand continuing. Potential capacity expansion for export opportunities is a medium-term value driver. Analyst targets range Rs 12,000 to Rs 16,000 for Paushak post Q4 results.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Article\"><\/span><strong>Recent Article<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/why-is-ahlucont-share-price-falling-key-reasons-2026\">Why Is Ahluwalia Contracts Share Price Falling Key Reasons 2026<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-ahlucont-share-price-falling-key-reasons-2026\">Why Is Ahluwalia Contracts Share Price Falling Key Reasons 2026<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-nuvoco-share-price-falling-key-reasons-2026\">Why Is Nuvoco Vistas Corporation Share Price Falling Key Reasons 2026<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-capacite-share-price-falling-key-reasons-2026\">Why Is Capacite Infraprojects Share Price Falling Key Reasons 2026<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-psp-projects-share-price-falling-key-reasons-2026\">Why Is PSP Projects Share Price Falling Key Reasons 2026<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Paushak Q4 results FY26: PAT Rs 12.51 crore, phosgene-based specialty chemicals, Alembic Group company, pharma and agrochemical ingredient manufacturing steady performance.<\/p>\n","protected":false},"author":26,"featured_media":82622,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-82513","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1778062094:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["76"],"rank_math_focus_keyword":["Paushak Q4"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Paushak Q4 Results FY26 PAT Rs 13 Crore Phosgene Specialty Chemicals Alembic Group"],"rank_math_description":["Paushak Q4 results FY26: PAT Rs 12.51 crore, phosgene-based specialty chemicals, Alembic Group company, pharma and agrochemical ingredient manufacturing steady performance."],"_thumbnail_id":["82622"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["10455"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/06153700\/Paushak-Q4-Results-FY26.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/82513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=82513"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/82513\/revisions"}],"predecessor-version":[{"id":82623,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/82513\/revisions\/82623"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/82622"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=82513"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=82513"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=82513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}